These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1151132)

  • 1. In vitro formation and i vivo clearance of fibrinogen: fibrin complexes.
    Sherman LA; Harwig S; Lee J
    J Lab Clin Med; 1975 Jul; 86(1):100-11. PubMed ID: 1151132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitation of the reticuloendothelial system clearance of soluble fibrin.
    Sherman LA; Lee J; Jacobson A
    Br J Haematol; 1977 Oct; 37(2):231-8. PubMed ID: 603756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Studies on circulating soluble fibrin: separation of 125I-Des-AB fibrin and 131I-fibrinogen by gel filtration.
    Kröhnke I; Mahn I; Krell W; Müller-Berghaus G
    Br J Haematol; 1980 May; 45(1):131-41. PubMed ID: 6769465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Soluble complexes of the NH2-terminal disulfide knot of fibrin with molecules containing D domains].
    Pozdniakova TM; Rybachuk VN; Vovk EV
    Ukr Biokhim Zh (1978); 1983; 55(6):614-21. PubMed ID: 6659078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin.
    Siebenlist KR; Meh DA; Mosesson MW
    Thromb Haemost; 2001 Nov; 86(5):1221-8. PubMed ID: 11816711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of blood coagulation factor XIII and fibrinogen by thrombin during in vitro clotting.
    Greenberg CS; Miraglia CC; Rickles FR; Shuman MA
    J Clin Invest; 1985 May; 75(5):1463-70. PubMed ID: 2860124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stabilization of soluble fibrin-fibrinogen complexes by fibrin stabilizing factor (FSF).
    Ly B; Kierulf P; Jakobsen E
    Thromb Res; 1974 Apr; 4(4):509-22. PubMed ID: 4429641
    [No Abstract]   [Full Text] [Related]  

  • 8. Separation of human plasma fibrin stabilizing factor (factor XIII) from fibrinogen by fibrinogen polymer formation.
    Becker CM
    Biochem Biophys Res Commun; 1986 Jan; 134(2):678-84. PubMed ID: 3947344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of intravascular fibrin deposition by dipyridamole in experimental animals.
    Gurewich V; Lipinski B; Wetmore R
    Blood; 1975 Apr; 45(4):569-75. PubMed ID: 1090312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma factor XIII binds specifically to fibrinogen molecules containing gamma chains.
    Siebenlist KR; Meh DA; Mosesson MW
    Biochemistry; 1996 Aug; 35(32):10448-53. PubMed ID: 8756701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of soluble fibrin complexes by agarose gel chromatography and protamine sulfate gelation.
    Latallo ZS; Mattler LE; Bang NU; Hansen MS; Chang ML
    Biochim Biophys Acta; 1976 Jan; 420(1):69-80. PubMed ID: 1247582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble fibrin-fibrinogen complexes as intermediates in fibrin gel formation.
    Wilf J; Minton AP
    Biochemistry; 1986 Jun; 25(11):3124-33. PubMed ID: 3730352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the basic mechanisms of fibrinogen to fibrin conversion and of fibrinolysis: intravascular coagulation versus primary fibrinolysis.
    Colick JA; Fisher LM
    Va Med Mon (1918); 1970 May; 97(5):310-4 passimass. PubMed ID: 4276992
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cross-linking on clearance of circulating alpha-fibrin monomer and its complexes.
    Shainoff JR; Dardik BN
    J Lab Clin Med; 1990 Mar; 115(3):314-23. PubMed ID: 1968950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of formation of fibrin oligomers. III. Ligation kinetics concurrent with and subsequent to oligomer assembly.
    Bale MD; Janmey PA; Ferry JD; Lorand L
    Biopolymers; 1984 Jan; 23(1):127-38. PubMed ID: 6141816
    [No Abstract]   [Full Text] [Related]  

  • 16. Crosslinking of fibrinogen to immobilized DesAA-fibrin.
    Selmayr E; Thiel W; Müller-Berghaus G
    Thromb Res; 1985 Aug; 39(4):459-65. PubMed ID: 4049326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble fibrin complexes: separation as a function of pH and characterization.
    Benabid Y; Concord E; Suscillon M
    Thromb Haemost; 1977 Feb; 37(1):144-53. PubMed ID: 14416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human plasma factor XIII: subunit interactions and activation of zymogen.
    Lorand L; Jeong JM; Radek JT; Wilson J
    Methods Enzymol; 1993; 222():22-35. PubMed ID: 8105367
    [No Abstract]   [Full Text] [Related]  

  • 19. Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII.
    Mattheij NJ; Swieringa F; Mastenbroek TG; Berny-Lang MA; May F; Baaten CC; van der Meijden PE; Henskens YM; Beckers EA; Suylen DP; Nolte MW; Hackeng TM; McCarty OJ; Heemskerk JW; Cosemans JM
    Haematologica; 2016 Apr; 101(4):427-36. PubMed ID: 26721892
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gel filtration of 125I-fibrin and 131I-fibrinogen at 20 degrees C and 37 degrees C.
    Krell W; Mahn I; Müller-Berghaus G
    Thromb Res; 1979; 14(2-3):299-310. PubMed ID: 442008
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.